Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off. After the very challenging, but also successful last two years, we at EUROIMMUN have decided to support charitable projects for the benefit of disadvantaged children financially at the end of this […]
We are delighted to welcome Immunodiagnostic Systems Holding (IDS) as the newest member of the PerkinElmer family. The acquisition of the British diagnostics company was officially closed in July 2021. In future, IDS and EUROIMMUN will closely cooperate in the fields of research and development, production as well as distribution. IDS is a leading company
Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN Medizinische Labordiagnostika AG. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect, in the European countries of Portugal, Italy, Turkey and Poland. The test is also expected
INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. INOCHEM becomes the 16th affiliate of the Luebeck, Germany-based company. INOCHEM’s relationship with EUROIMMUN spans more than 14 years, initally as sub-distributor of another
On 18 December 2019, our new EUROIMMUN subsidiary in Japan was officially founded after one year of hard work, intensive planning and structuring. Head of this new subsidiary is Cagla Egretaud, who has been working at EUROIMMUN for 20 years. The idea to jointly establish a new subsidiary in Japan, one of the world’s largest
